Study Evaluating the Efficacy of DVS-233 in Fibromyalgia

Stopped early · Phase 2/Phase 3

Conditions studied: Fibromyalgia

In brief

The purpose of this study is to determine if DVS-233 is safe and effective in the treatment of pain and other symptoms of fibromyalgia syndrome.

Key facts

Study ID
NCT00301431
Run by
Wyeth is now a wholly owned subsidiary of Pfizer
People needed
1050
Starts
2006-08-01
Expected to finish
2007-06-01
Last updated by the study team
2007-12-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.